l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
about
Fatality from hepatitis A in a child taking valproate.Hyperammonemia associated with valproic acid concentrations.The role of carnitine supplementation during valproic acid therapy.Valproic acid toxicity: overview and management.The fatty acid beta-oxidation pathway is important for decidualization of endometrial stromal cells in both humans and mice.Idiosyncratic adverse reactions to antiepileptic drugs.Carnitine in the treatment of valproic acid-induced toxicity.Influences of bone and mineral metabolism in epilepsy.Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes.Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.Markers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs.Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia.L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.Valproic acid-associated vanishing bile duct syndrome.Carnitine levels and the ketogenic diet.Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.L-carnitine reduces brain injury after hypoxia-ischemia in newborn rats.Serum and muscle carnitine levels in epileptic children receiving sodium valproate.Sodium valproate -- induced skeletal myopathy.Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy.Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet.Early- and late-onset complications of the ketogenic diet for intractable epilepsy.Screening of carnitine and biotin deficiencies on tandem mass spectrometry.Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation.
P2860
Q33331643-8A1856AC-3E96-4CE8-B346-1E6787642AAAQ33608984-21118185-9AE1-4FD0-A337-A23768A832D0Q33941948-C5C81B37-CA75-4DE5-997A-9D9902690568Q33963043-871BEC8D-B682-4C13-9F57-7A56077F0FA0Q35617582-1EAE0200-8497-4F81-B613-B27090FCEE5AQ36770454-F3BEB188-215F-4BCD-A514-BEEAD1A73D00Q37413086-E337A73B-8B25-424D-A787-9FAAEEE96912Q37842459-07EE6DE8-6FDE-45CD-943E-53397637FF7BQ38027585-F5A56BAE-A025-439C-A36C-3409BA67FF83Q38084857-B2701A17-FE5E-4000-AF1A-CE0DEDEEA9E9Q38171391-6DDD4B1A-A683-4C11-9FEB-59E348034710Q38640619-FA20F380-DDAD-4CEF-973C-EE0A13EAC156Q41338021-21A40EF0-59DA-4F35-AEE4-AF86F0AEEBBAQ41864413-2EA96751-14D9-441C-BEAD-A8966DACA526Q43100910-78743365-8A95-4DBA-AFB2-A7DE7A3F768AQ43906044-2C0149A7-BFAB-4744-AB25-C41D17B2BFEEQ43923337-D3D87EC9-1A32-4C05-AE09-1BBD0A32EAA4Q44540675-D0F7C707-8682-434E-AF58-CBCB4DD087F1Q46147751-6154F636-F63A-4DF8-80C7-C8C02CEC96D8Q46423634-109E8281-1F30-4F35-81E1-628F2E55C7BEQ46690424-77486758-1320-42FB-9655-306C95F6AFFAQ46780453-1552CB93-23A3-45DB-9A10-1701D773379EQ47317392-733FB9E8-EFC6-489F-9D4A-F914B2464A60Q51528042-F1391B2C-E28E-46AA-977F-237176E7076CQ53769539-370D9EEB-0F2E-45F6-AB50-9A6DCC2BEA96Q54334767-DAA04688-C82F-4240-A1BE-12CCB082FA63
P2860
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
description
article
@en
im November 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 1998
@uk
ലേഖനം
@ml
name
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
@en
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
@nl
type
label
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
@en
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
@nl
prefLabel
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
@en
l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
@nl
P2093
P2860
P1433
P1476
L-carnitine supplementation in childhood epilepsy: current perspectives
@en
P2093
C E Stafstrom
D C De Vivo
D L Coulter
D R Nordli
F E Dreifuss
R S Greenwood
W D Shields
P2860
P304
P356
10.1111/J.1528-1157.1998.TB01315.X
P577
1998-11-01T00:00:00Z